-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Kiromic Biopharma, Inc. quarterly/annual Depreciation history and growth rate from Q3 2019 to Q3 2024.
- Kiromic Biopharma, Inc. Depreciation for the quarter ending September 30, 2024 was $552K, a 1.43% decline year-over-year.
- Kiromic Biopharma, Inc. Depreciation for the twelve months ending September 30, 2024 was $2.22M, a 0.01% increase year-over-year.
- Kiromic Biopharma, Inc. annual Depreciation for 2023 was $2.22M, a 32.7% increase from 2022.
- Kiromic Biopharma, Inc. annual Depreciation for 2022 was $1.67M, a 256% increase from 2021.
- Kiromic Biopharma, Inc. annual Depreciation for 2021 was $470K, a 135% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)